Pressure BioSciences, Inc. provided earnings guidance for the first quarter of 2023. For the quarter, the company expected to release results with record revenue exceeding any quarter in history.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2253 USD | -0.66% | -8.04% | -31.73% |
1st Jan change | Capi. | |
---|---|---|
-31.73% | 7.63M | |
-2.45% | 187B | |
-1.80% | 106B | |
-4.29% | 66.9B | |
+0.36% | 49.45B | |
+16.30% | 48B | |
+4.06% | 40.84B | |
+3.28% | 26.48B | |
+1.41% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- PBIO Stock
- News Pressure BioSciences, Inc.
- Pressure BioSciences, Inc. Provides Earnings Guidance for the First Quarter of 2023